In two separate papers, Massimo Pizzato and colleagues and Heinrich Göttlinger and colleagues identify previously unrecognized restriction factors for HIV-1. In the absence of the HIV-1 Nef protein, the multipass transmembrane proteins SERINC3 and SERINC5 become incorporated into assembling virions and profoundly block HIV-1 infection. The Nef protein, which is normally expressed by HIV-1, counteracts this activity by down-regulating SERINC3 and SERINC5 from the cell surface, thereby preventing their incorporation into virions. These findings identify SERINC5, and to a lesser extent SERINC3, as the agents responsible for the long-sought anti-HIV-1 activity that is overcome by Nef. This raises the possibility that SERINC5 might have potential as a basis for anti-HIV-1 therapeutics.
- HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation (Article p212, doi: 10.1038/nature15399)
- SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef (Article p218, doi: 10.1038/nature15400)
- Antiviral action countered by Nef (News & Views p202, doi: 10.1038/nature15637)
Recent Hot Topics
Sign up for Nature Research e-alerts to get the lastest research in your inbox every week.